Financhill
Back

Oramed Pharmaceuticals Quote, Financials, Valuation and Earnings

Oramed Pharmaceuticals Price Quote

$2.33
+0.07 (+3.1%)
(Updated: November 21, 2024 at 5:55 PM ET)

Oramed Pharmaceuticals Key Stats

Sell
40
Oramed Pharmaceuticals (ORMP) is a Sell

Day range:
$2.26 - $2.30
52-week range:
$2.00 - $3.67
Dividend yield:
0%
P/E ratio:
15.50
P/S ratio:
33.23
P/B ratio:
0.56%

Volume:
60.9K
Avg. volume:
96.6K
1-year change:
4.63%
Market cap:
$87.5M
Revenue:
$1.3M
EPS:
$0.11

How Much Does Oramed Pharmaceuticals Make?

Data Unavailable

Is Oramed Pharmaceuticals Growing As A Company?

Data Unavailable

Oramed Pharmaceuticals Stock Price Performance

What Is Oramed Pharmaceuticals 52-Week High & Low?

Oramed Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Oramed Pharmaceuticals?

Is Oramed Pharmaceuticals Cash Flow Positive?

  • What Is ORMP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.9M
  • What Is Oramed Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$75.8M
  • What Is Oramed Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $120.4M

Oramed Pharmaceuticals Return On Invested Capital

Data Unavailable

Oramed Pharmaceuticals Earnings Date & Stock Price

Oramed Pharmaceuticals Competitors

Oramed Pharmaceuticals Dividend Yield

Oramed Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2300%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 3.25
Upside from Last Price: 43.81%

Major Shareholders

  • How many ORMP shares are owned by institutional investors?
    7.2M ORMP shares are owned by institutional investors
  • How many ORMP shares are owned by insiders?
    20.4M ORMP shares are owned by insiders